These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

939 related items for PubMed ID: 15753888

  • 1. The anti-inflammatory effects of omalizumab confirm the central role of IgE in allergic inflammation.
    Holgate S, Casale T, Wenzel S, Bousquet J, Deniz Y, Reisner C.
    J Allergy Clin Immunol; 2005 Mar; 115(3):459-65. PubMed ID: 15753888
    [Abstract] [Full Text] [Related]

  • 2. Anti-immunoglobulin E treatment with omalizumab in allergic diseases: an update on anti-inflammatory activity and clinical efficacy.
    Holgate ST, Djukanović R, Casale T, Bousquet J.
    Clin Exp Allergy; 2005 Apr; 35(4):408-16. PubMed ID: 15836747
    [Abstract] [Full Text] [Related]

  • 3. Management of asthma with anti-immunoglobulin E: a review of clinical trials of omalizumab.
    Nowak D.
    Respir Med; 2006 Nov; 100(11):1907-17. PubMed ID: 16949266
    [Abstract] [Full Text] [Related]

  • 4. Immunoglobulin E: role in asthma and allergic disease: lessons from the clinic.
    Owen CE.
    Pharmacol Ther; 2007 Jan; 113(1):121-33. PubMed ID: 17000005
    [Abstract] [Full Text] [Related]

  • 5. Monoclonal anti-IgE antibody: a novel therapy for allergic airways disease.
    Berger WE.
    Ann Allergy Asthma Immunol; 2002 Feb; 88(2):152-60; quiz 161-2, 208. PubMed ID: 11868919
    [Abstract] [Full Text] [Related]

  • 6. Role of anti-IgE monoclonal antibody (omalizumab) in the treatment of bronchial asthma and allergic respiratory diseases.
    D'Amato G.
    Eur J Pharmacol; 2006 Mar 08; 533(1-3):302-7. PubMed ID: 16464445
    [Abstract] [Full Text] [Related]

  • 7. Anti-IgE therapy with omalizumab in asthma and allergic rhinitis.
    Dodig S, Richter D, Cepelak I, Benko B.
    Acta Pharm; 2005 Jun 08; 55(2):123-38. PubMed ID: 16179127
    [Abstract] [Full Text] [Related]

  • 8. Omalizumab: efficacy in allergic disease.
    Spector S.
    Panminerva Med; 2004 Jun 08; 46(2):141-8. PubMed ID: 15507883
    [Abstract] [Full Text] [Related]

  • 9. Efficacy and tolerability of anti-immunoglobulin E therapy with omalizumab in patients with concomitant allergic asthma and persistent allergic rhinitis: SOLAR.
    Vignola AM, Humbert M, Bousquet J, Boulet LP, Hedgecock S, Blogg M, Fox H, Surrey K.
    Allergy; 2004 Jul 08; 59(7):709-17. PubMed ID: 15180757
    [Abstract] [Full Text] [Related]

  • 10. IgE-Fc epsilonRI-mast cell axis in the allergic cycle.
    Pawankar R, Ra C.
    Clin Exp Allergy; 1998 Aug 08; 28 Suppl 3():6-14. PubMed ID: 9756181
    [Abstract] [Full Text] [Related]

  • 11. Omalizumab rapidly decreases nasal allergic response and FcepsilonRI on basophils.
    Lin H, Boesel KM, Griffith DT, Prussin C, Foster B, Romero FA, Townley R, Casale TB.
    J Allergy Clin Immunol; 2004 Feb 08; 113(2):297-302. PubMed ID: 14767445
    [Abstract] [Full Text] [Related]

  • 12. Anti-IgE antibodies for the treatment of IgE-mediated allergic diseases.
    Chang TW, Wu PC, Hsu CL, Hung AF.
    Adv Immunol; 2007 Feb 08; 93():63-119. PubMed ID: 17383539
    [Abstract] [Full Text] [Related]

  • 13. Anti-IgE therapy of asthma.
    Chung KF.
    Curr Opin Investig Drugs; 2002 Aug 08; 3(8):1157-60. PubMed ID: 12211407
    [Abstract] [Full Text] [Related]

  • 14. Therapy of allergic bronchial asthma with omalizumab - an anti-IgE monoclonal antibody.
    D'Amato G.
    Expert Opin Biol Ther; 2003 Apr 08; 3(2):371-6. PubMed ID: 12662149
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Anti-IgE for the treatment of allergic rhinitis--and eventually nasal polyps?
    Verbruggen K, Van Cauwenberge P, Bachert C.
    Int Arch Allergy Immunol; 2009 Apr 08; 148(2):87-98. PubMed ID: 18799888
    [Abstract] [Full Text] [Related]

  • 18. Effects of treatment with anti-immunoglobulin E antibody omalizumab on airway inflammation in allergic asthma.
    Djukanović R, Wilson SJ, Kraft M, Jarjour NN, Steel M, Chung KF, Bao W, Fowler-Taylor A, Matthews J, Busse WW, Holgate ST, Fahy JV.
    Am J Respir Crit Care Med; 2004 Sep 15; 170(6):583-93. PubMed ID: 15172898
    [Abstract] [Full Text] [Related]

  • 19. Omalizumab: a novel therapy for allergic asthma.
    Davis LA.
    Ann Pharmacother; 2004 Sep 15; 38(7-8):1236-42. PubMed ID: 15187202
    [Abstract] [Full Text] [Related]

  • 20. Effect of omalizumab on the need for rescue systemic corticosteroid treatment in patients with moderate-to-severe persistent IgE-mediated allergic asthma: a pooled analysis.
    Busse WW, Massanari M, Kianifard F, Geba GP.
    Curr Med Res Opin; 2007 Oct 15; 23(10):2379-86. PubMed ID: 17711616
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 47.